Search clinical trials for: ATMX

Total 105 results

University of Arizona

Completed

Atomoxetine Pilot Study in Preschool Children With ADHD

Attention Deficit Hyperactivity Disorder

United States
U.S. Army Medical Research and Development Command

Completed

mTBI Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms (BIMA)

Post-Concussion Syndrome | Traumatic Brain Injury With Brief Loss of Consciousness

United States
Uppsala University Hospital

Recruiting

Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents

Type1diabetes

Sweden
Benjamin Izar

Terminated

ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma (ATX-101)

Leiomyosarcoma | Liposarcoma

United States
Atmo Biosciences Pty Ltd
University of Western Sydney

Completed

Atmo SmartPill Comparison in Gastroparetic and Slow Transit Constipation Patients

Gastroparesis | Slow Transit

Australia
University of Zurich
University Hospital Tuebingen; Salzburger Landeskliniken

Completed

Multisystem Cell Therapy for Improvement of Urinary Continence (MUSIC)

Urinary Stress Incontinence

Switzerland
Kythera Biopharmaceuticals

Completed

Open-Label Pharmacokinetic Study of Final Formulations of ATX-101

Healthy

United States
Amytrx Therapeutics, Inc.
Amarex Clinical Research

Completed

Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
Apitope International NV
Quintiles, Inc.; European Commission

Completed

ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy

Graves Disease

United Kingdom
Teijin America, Inc.

Completed

Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria

Diabetic Kidney Disease

United States
Apitope Technology (Bristol) Ltd.
Aptiv Solutions; ClinStar, LLC

Completed

ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis

United Kingdom, Russian Federation
Kythera Biopharmaceuticals

Completed

A Study to Assess Injection Comfort of Two Formulations of ATX-101

Healthy

United States
Kythera Biopharmaceuticals

Completed

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Healthy | Submental Fat

United States, Canada, Australia, United Kingdom
Holostem Terapie Avanzate s.r.l.
Paracelsus Medical University

Terminated

Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB. (HOLOGENE7)

Recessive Dystrophic Epidermolysis Bullosa

Austria
Artios Pharma Ltd

Completed

Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein (ATM)

Solid Tumor, Unspecified, Adult

United States, United Kingdom
Athersys, Inc
Syneos Health

Withdrawn

A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety

Obesity
Holostem Terapie Avanzate s.r.l.
Paracelsus Medical University

Terminated

Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With JEB (HOLOGENE17) (HOLOGENE17)

Junctional Epidermolysis Bullosa

Austria
Merck KGaA, Darmstadt, Germany

Completed

ATX-MS-1467 in Multiple Sclerosis

Multiple Sclerosis

Germany
Kythera Biopharmaceuticals

Completed

To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101

Healthy

United States
Kythera Biopharmaceuticals

Completed

Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue

Healthy

United States
Kythera Biopharmaceuticals

Completed

ATX-101 Abdominoplasty (ATX-101-08-10)

Characteristics of Subcutaneous Fat

United States
Medical University of South Carolina

Completed

Atomoxetine for Freezing of Gait in Parkinson's Disease (ATMFOG)

Parkinson's Disease | Freezing of Gait

United States
Kythera Biopharmaceuticals

Completed

Dose-Escalation Safety and Pharmacokinetic Study of ATX-101

Healthy

United States
Kythera Biopharmaceuticals

Completed

Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Healthy | Submental Fat

United States, Canada
ARTHEx Biotech S.L.

Not yet recruiting

Study of ATX-01 in Participants With DM1 (ArthemiR)

Myotonic Dystrophy 1
Amunix, a Sanofi Company

Recruiting

Safety, Pharmacokinetics, and Preliminary Efficacy of AMX-500 in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Hormone-refractory Prostate Cancer

Australia, Spain, United Kingdom
Hospices Civils de Lyon

Recruiting

Lysophosphatidic Acid / Autotaxin Axis in Rheumatoid Lung Disease (LYSLUNG)

Rheumatoid Arthritis

France
AstraZeneca

Recruiting

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Recurrent Glioblastoma Multiforme | Brain Neoplasms, Malignant | Primary Glioblastoma Multiforme | Leptomeningeal Disease (LMD)

United States, United Kingdom
Atmo Biosciences Pty Ltd

Active, not recruiting

Comparison of the Atmo Motility Gas Capsule System to the Reference Standard

Gastroparesis | IBS | Slow Transit Constipation

United States
SK Chemicals Co., Ltd.

Completed

Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy Volunteers

Gout

Korea, Republic of
Pfizer
Biomedical Advanced Research and Development Authority; Innovative Medicines...

Completed

A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. (REVISIT)

Ventilator Associated Pneumonia | Complicated Intra-abdominal Infection | Hosptial Acquired Pneumonia

Spain, China, Korea, Republic of, Philippines, United States, Romania, Taiwan, Italy, Malaysia, Mexico, India, Israel, Turkey, Greece, Thailand, Czechia, Croatia, Argentina, Russian Federation, Bulgaria, Ukraine
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Abstinence-Linked Money Management Multisite

Dual Diagnosis | Cocaine Dependence | Polysubstance Abuse | Cocaine Abuse

United States
Takeda

Terminated

Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina

Angina

United States
Intermountain Health Care, Inc.

Completed

Test of Chamber Pressure to Divers and Chamber Attendants (TOP-DIVER)

Traumatic Brain Injury

United States
Takeda

Completed

Long-Term Safety of Febuxostat in Subjects With Gout. (FOCUS)

Gout
Takeda

Completed

Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment

Renal Impairment

United States
University of Arizona
National Cancer Institute (NCI)

Recruiting

Adaptive Symptom Self-Management Immunotherapy Study

Breast Cancer | Lung Cancer | Skin Cancer | Colon Cancer | Rectum Cancer

United States
Encore Research Inc.
CoolSystems, Inc.

Completed

Cryopneumatic Device After Shoulder Surgeries

Shoulder Injuries | Shoulder Disease

Canada
Takeda

Completed

Effect of Febuxostat on Blood Pressure

Hypertension

United States
University of Guarulhos

Unknown

Metronidazole and Amoxicillin for the Treatment of Type 2 Diabetic Subjects With Periodontitis

Periodontitis

Brazil
Pfizer

Completed

To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)

Bacterial Infections | Complicated Infection

United Kingdom
Takeda

Completed

Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout

Joint Damage

United States
Takeda

Completed

Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout

Gout
Kythera Biopharmaceuticals
Bayer

Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Moderate or Severe Submental Fullness

Germany, France, Belgium, Spain, United Kingdom
Kythera Biopharmaceuticals

Completed

Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat (ATX-101)

Moderate or Severe Submental Fullness

United Kingdom, Canada, Australia
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute

Completed

Recombinant H7 Hemagglutinin Influenza Vaccine Trial (FLU007)

Influenza, Avian

Australia
Northwestern University

Active, not recruiting

Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back Fat

Upper Back Fat

United States
Pfizer
Innovative Medicines Initiative (IMI) COMBACTE-CARE

Completed

Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)

Complicated Intra-Abdominal Infections, cIAIs

Spain, France, Germany
Kythera Biopharmaceuticals

Completed

Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age

Efficacy | Safety | Moderate to Severe Convexity of Submental Fat

United States
Kythera Biopharmaceuticals

Completed

Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area

Moderate or Severe Submental Fullness

United States

Search clinical trials for: ATMX

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations